Is Elevation Oncology, Inc. (ELEV) a Buy, Sell, or Hold?
NASDAQ : ELEV
Elevation Oncology, Inc. — Institutional Ownership
$0.365 USD
-$0.01 (-2.12%)
- Volume
- 4.82M
- Average Volume
- 1.35M
- Market Capitalization
- $21.63M
- P/E Ratio
- -0.47
- Dividend Yield
- 0.00%
- Price Target
- $9.00
- Year High
- $3.09
- Year Low
- $0.22
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $21.21
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2025-08-14 | TANG CAPITAL MANAGEMENT, LLC | 3.12M | 5.00% |
| 2025-08-14 | Frazier Life Sciences Public Fund, L.P. | - | 0.00% |
| 2025-07-28 | BML Investment Partners, L.P. | - | 0.00% |
| 2025-07-17 | BlackRock, Inc. | 369.05K | 0.60% |
| 2025-05-15 | TANG CAPITAL MANAGEMENT, LLC | 6.04M | 9.99% |
| 2025-05-15 | BIOTECHNOLOGY VALUE FUND L P | 2.37M | 3.90% |
| 2025-05-07 | Farallon Capital Partners, L.P. | - | 0.00% |
| 2025-04-16 | BML Investment Partners, L.P. | 5.89M | 9.90% |
| 2025-03-26 | BML Investment Partners, L.P. | 5.89M | 9.90% |
| 2025-02-14 | Logos Global Management LP | - | 0.00% |
| 2025-02-06 | THE GOLDMAN SACHS GROUP, INC. | 1.68M | 2.80% |
| 2025-02-05 | Farallon Capital Partners, L.P. | 733.6K | 1.20% |
| 2025-02-04 | BlackRock, Inc. | 3.16M | 5.40% |
| 2025-01-30 | The Vanguard Group | 2.61M | 4.41% |
| 2024-11-06 | THE GOLDMAN SACHS GROUP, INC. | 4.52M | 7.60% |
| 2024-11-06 | GOLDMAN SACHS & CO. LLC | 4.52M | 7.60% |
| 2024-08-15 | Great Point Partners, LLC | 3.88M | 6.56% |
| 2024-08-15 | Mr. Ortav Yehudai | 3.88M | 6.56% |
| 2024-08-15 | Great Point Partners, LLC | 3.88M | 6.56% |
| 2024-08-15 | Mr. Ortav Yehudai | 3.88M | 6.56% |
| 2024-08-15 | Dr. Jeffrey R. Jay, M.D. | 3.88M | 6.56% |
| 2024-08-15 | Dr. Jeffrey R. Jay, M.D. | 3.88M | 6.56% |
| 2024-04-09 | FHMLS XI, L.L.C. | 458.88K | 0.90% |
| 2024-04-09 | FHMLS X, L.L.C. | 261.83K | 0.50% |
| 2024-04-09 | James Brush | 2.24M | 4.60% |
| 2024-04-09 | Albert Cha | 2.24M | 4.60% |
| 2024-04-09 | Frazier Life Sciences X, L.P. | 261.83K | 0.50% |
| 2024-04-09 | FHMLSP Overage, L.L.C. | 751.48K | 1.50% |
| 2024-04-09 | FHMLSP, L.L.C. | 1.49M | 3.10% |
| 2024-04-09 | FHMLSP, L.L.C. | 1.49M | 3.10% |
| 2024-04-09 | FHMLSP, L.P. | 1.49M | 3.10% |
| 2024-04-09 | Patrick J. Heron | 2.96M | 6.10% |
| 2024-04-09 | James N. Topper | 2.96M | 6.10% |
| 2024-04-09 | Daniel Estes | 458.88K | 0.90% |
| 2024-04-09 | Frazier Life Sciences Public Fund, L.P. | 1.49M | 3.10% |
| 2024-04-09 | Frazier Life Sciences Public Fund, L.P. | 1.49M | 3.10% |
| 2024-04-09 | Frazier Life Sciences XI, L.P. | 458.88K | 0.90% |
| 2024-04-09 | FHMLSP Overage, L.P. | 751.48K | 1.50% |
| 2024-04-09 | James Brush | 2.24M | 4.60% |
| 2024-04-09 | FHMLS X, L.P. | 261.83K | 0.50% |
| 2024-04-09 | FHMLSP, L.P. | 1.49M | 3.10% |
| 2024-04-09 | FHMLS XI, L.P. | 458.88K | 0.90% |
| 2024-04-09 | Frazier Life Sciences XI, L.P. | 458.88K | 0.90% |
| 2024-04-09 | FHMLS X, L.P. | 261.83K | 0.50% |
| 2024-04-09 | Frazier Life Sciences X, L.P. | 261.83K | 0.50% |
| 2024-04-09 | James N. Topper | 2.96M | 6.10% |
| 2024-04-09 | Patrick J. Heron | 2.96M | 6.10% |
| 2024-04-09 | Albert Cha | 2.24M | 4.60% |
| 2024-04-09 | FHMLS XI, L.L.C. | 458.88K | 0.90% |
| 2024-04-09 | Frazier Life Sciences Public Overage Fund, L.P. | 751.48K | 1.50% |
| 2024-04-09 | Frazier Life Sciences Public Overage Fund, L.P. | 751.48K | 1.50% |
| 2024-04-09 | FHMLSP Overage, L.P. | 751.48K | 1.50% |
| 2024-04-09 | Daniel Estes | 458.88K | 0.90% |
| 2024-04-09 | FHMLS XI, L.P. | 458.88K | 0.90% |
| 2024-04-09 | FHMLSP Overage, L.L.C. | 751.48K | 1.50% |
| 2024-04-09 | FHMLS X, L.L.C. | 261.83K | 0.50% |
| 2024-02-14 | OrbiMed Genesis GP LLC | 3M | 6.80% |
| 2024-02-14 | OrbiMed Advisors LLC | 3M | 6.80% |
| 2024-02-14 | OrbiMed Advisors LLC | 3M | 6.80% |
| 2024-02-14 | OrbiMed Genesis GP LLC | 3M | 6.80% |
| 2024-01-22 | Logos Global Management LP | 3.65M | 11.00% |
| 2024-01-22 | Arsani William | 3.65M | 11.00% |
| 2024-01-22 | Logos Global Management GP LLC | 3.65M | 11.00% |
| 2024-01-22 | Joshua J. Dapice | 3.1M | 7.30% |
| 2024-01-22 | Arsani William | 3.65M | 11.00% |
| 2024-01-22 | Logos Global Management GP LLC | 3.65M | 11.00% |
| 2024-01-22 | Farallon Partners, L.L.C. | 2.74M | 6.50% |
| 2024-01-22 | Logos Global Management LP | 3.65M | 11.00% |
| 2024-01-22 | Farallon Capital Institutional Partners, L.P. | 580.4K | 1.40% |
| 2024-01-22 | Farallon Capital Institutional Partners II, L.P. | 198.2K | 0.50% |
| 2024-01-22 | Four Crossings Institutional Partners V, L.P. | 122.2K | 0.30% |
| 2024-01-22 | Farallon Capital Offshore Investors II, L.P. | 1.05M | 2.50% |
| 2024-01-22 | Farallon F5 (GP), L.L.C. | 356.8K | 0.80% |
| 2024-01-22 | Philip D. Dreyfuss | 3.1M | 7.30% |
| 2024-01-22 | David T. Kim | 3.1M | 7.30% |
| 2024-01-22 | Michael G. Linn | 3.1M | 7.30% |
| 2024-01-22 | Daniel S. Short | 3.1M | 7.30% |
| 2024-01-22 | Mark C. Wehrly | 3.1M | 7.30% |
| 2024-01-22 | John R. Warren | 3.1M | 7.30% |
| 2024-01-22 | Logos Global Master Fund LP | 3.65M | 11.00% |
| 2024-01-22 | Farallon Capital Partners, L.P. | 649.5K | 1.50% |
| 2024-01-22 | Farallon Capital Institutional Partners, L.P. | 580.4K | 1.40% |
| 2024-01-22 | Farallon Capital Institutional Partners II, L.P. | 198.2K | 0.50% |
| 2024-01-22 | Mark C. Wehrly | 3.1M | 7.30% |
| 2024-01-22 | Farallon Capital Institutional Partners III, L.P. | 69800.0 | 0.20% |
| 2024-01-22 | Rajiv A. Patel | 3.1M | 7.30% |
| 2024-01-22 | Varun N. Gehani | 3.1M | 7.30% |
| 2024-01-22 | Farallon Institutional (GP) V, L.L.C. | 122.2K | 0.30% |
| 2024-01-22 | Farallon F5 (GP), L.L.C. | 356.8K | 0.80% |
| 2024-01-22 | Joshua J. Dapice | 3.1M | 7.30% |
| 2024-01-22 | Philip D. Dreyfuss | 3.1M | 7.30% |
| 2024-01-22 | Hannah E. Dunn | 3.1M | 7.30% |
| 2024-01-22 | Richard B. Fried | 3.1M | 7.30% |
| 2024-01-22 | Nicolas Giauque | 3.1M | 7.30% |
| 2024-01-22 | David T. Kim | 3.1M | 7.30% |
| 2024-01-22 | Thomas G. Roberts, Jr. | 3.1M | 7.30% |
| 2024-01-22 | Edric C. Saito | 3.1M | 7.30% |
| 2024-01-22 | William Seybold | 3.1M | 7.30% |
| 2024-01-22 | Logos GP LLC | 3.65M | 11.00% |
| 2024-01-22 | Andrew J. M. Spokes | 3.1M | 7.30% |
| 2024-01-22 | Daniel S. Short | 3.1M | 7.30% |
| 2024-01-22 | Farallon Partners, L.L.C. | 2.74M | 6.50% |
| 2024-01-22 | Farallon Capital (AM) Investors, L.P. | 74800.0 | 0.20% |
| 2024-01-22 | Farallon Capital F5 Master I, L.P. | 356.8K | 0.80% |
| 2024-01-22 | Farallon Capital Offshore Investors II, L.P. | 1.05M | 2.50% |
| 2024-01-22 | Michael G. Linn | 3.1M | 7.30% |
| 2024-01-22 | John R. Warren | 3.1M | 7.30% |
| 2024-01-22 | Andrew J. M. Spokes | 3.1M | 7.30% |
| 2024-01-22 | William Seybold | 3.1M | 7.30% |
| 2024-01-22 | Edric C. Saito | 3.1M | 7.30% |
| 2024-01-22 | Logos Global Master Fund LP | 3.65M | 11.00% |
| 2024-01-22 | Four Crossings Institutional Partners V, L.P. | 122.2K | 0.30% |
| 2024-01-22 | Thomas G. Roberts, Jr. | 3.1M | 7.30% |
| 2024-01-22 | Rajiv A. Patel | 3.1M | 7.30% |
| 2024-01-22 | Nicolas Giauque | 3.1M | 7.30% |
| 2024-01-22 | Varun N. Gehani | 3.1M | 7.30% |
| 2024-01-22 | Richard B. Fried | 3.1M | 7.30% |
| 2024-01-22 | Hannah E. Dunn | 3.1M | 7.30% |
| 2024-01-22 | Farallon Institutional (GP) V, L.L.C. | 122.2K | 0.30% |
| 2024-01-22 | Farallon Capital (AM) Investors, L.P. | 74800.0 | 0.20% |
| 2024-01-22 | Farallon Capital F5 Master I, L.P. | 356.8K | 0.80% |
| 2024-01-22 | Farallon Capital Institutional Partners III, L.P. | 69800.0 | 0.20% |
| 2024-01-22 | Farallon Capital Partners, L.P. | 649.5K | 1.50% |
| 2024-01-22 | Logos GP LLC | 3.65M | 11.00% |
| 2024-01-09 | Ryan M. Lane | 4M | 6.70% |
| 2024-01-09 | Martin D. Hoe | 4M | 6.70% |
| 2024-01-09 | Empery Asset Management, LP | 4M | 6.70% |
| 2024-01-09 | Empery Asset Management, LP | 4M | 6.70% |
| 2024-01-09 | Ryan M. Lane | 4M | 6.70% |
| 2024-01-09 | Martin D. Hoe | 4M | 6.70% |
| 2023-06-09 | Michael Gelband | 1.41M | 5.80% |
| 2023-06-09 | Michael Gelband | 1.41M | 5.80% |
| 2023-06-09 | ExodusPoint Capital Partners GP, LLC | 1.41M | 5.80% |
| 2023-06-09 | Hyung Lee | 1.41M | 5.80% |
| 2023-06-09 | ExodusPoint Capital Partners GP, LLC | 1.41M | 5.80% |
| 2023-06-09 | ExodusPoint Capital Management, LP | 1.41M | 5.80% |
| 2023-06-09 | Hyung Lee | 1.41M | 5.80% |
| 2023-06-09 | ExodusPoint Capital Management, LP | 1.41M | 5.80% |
| 2023-06-08 | Israel A. Englander | 1.4M | 5.70% |
| 2023-06-08 | Integrated Core Strategies (US) LLC | 1.36M | 5.60% |
| 2023-06-08 | Millennium Management LLC | 1.4M | 5.70% |
| 2023-06-08 | Israel A. Englander | 1.4M | 5.70% |
| 2023-06-08 | Integrated Core Strategies (US) LLC | 1.36M | 5.60% |
| 2023-06-08 | Millennium Management LLC | 1.4M | 5.70% |
| 2023-06-08 | Millennium Group Management LLC | 1.4M | 5.70% |
| 2023-06-08 | Millennium Group Management LLC | 1.4M | 5.70% |
| 2023-05-24 | Point72 Capital Advisors, Inc. | 2.12M | 8.70% |
| 2023-05-24 | Steven A. Cohen | 2.12M | 8.70% |
| 2023-05-24 | Point72 Asset Management, L.P. | 2.12M | 8.70% |
| 2023-05-24 | Steven A. Cohen | 2.12M | 8.70% |
| 2023-05-24 | Point72 Capital Advisors, Inc. | 2.12M | 8.70% |
| 2023-05-24 | Point72 Asset Management, L.P. | 2.12M | 8.70% |
| 2022-09-30 | Anup Arora | 1.57M | 6.30% |
| 2022-09-30 | K2 HealthVentures Equity Trust LLC | 1.57M | 6.30% |
| 2022-09-30 | K2 HealthVentures Equity Trust LLC | 1.57M | 6.30% |
| 2022-09-30 | Parag Shah | 1.57M | 6.30% |
| 2022-09-30 | Anup Arora | 1.57M | 6.30% |
| 2022-09-30 | Parag Shah | 1.57M | 6.30% |
| 2022-02-14 | BVF GP Holdings LLC | 1.47M | 6.30% |
| 2022-02-14 | BVF Partners L.P. | 1.61M | 6.90% |
| 2022-02-14 | BVF Inc. | 1.61M | 6.90% |
| 2022-02-14 | Mark N. Lampert | 1.61M | 6.90% |
| 2022-02-14 | BVF Inc. | 1.61M | 6.90% |
| 2022-02-14 | BVF Partners L.P. | 1.61M | 6.90% |
| 2022-02-14 | BVF GP Holdings LLC | 1.47M | 6.30% |
| 2022-02-14 | BVF II GP LLC | 655.91K | 2.80% |
| 2022-02-14 | Biotechnology Value Fund II, L.P. | 655.91K | 2.80% |
| 2022-02-14 | BVF I GP LLC | 809.44K | 3.50% |
| 2022-02-14 | Biotechnology Value Fund, L.P. | 809.44K | 3.50% |
| 2022-02-14 | Joe Lewis | 872.78K | 3.80% |
| 2022-02-14 | Boxer Asset Management Inc. | 872.78K | 3.80% |
| 2022-02-14 | Boxer Capital, LLC | 872.78K | 3.80% |
| 2022-02-14 | DRIEHAUS CAPITAL MANAGEMENT LLC | 1.98M | 8.54% |
| 2022-02-14 | Steve Elms | 2.87M | 12.33% |
| 2022-02-14 | Aisling Capital Partners IV, LP | 2.87M | 12.33% |
| 2022-02-14 | Steve Elms | 2.87M | 12.33% |
| 2022-02-14 | Aisling Capital Partners IV, LP | 2.87M | 12.33% |
| 2022-02-14 | Boxer Asset Management Inc. | 872.78K | 3.80% |
| 2022-02-14 | Mark N. Lampert | 1.61M | 6.90% |
| 2022-02-14 | Aaron I. Davis | 56831.0 | 0.20% |
| 2022-02-14 | BVF Partners OS Ltd. | 107.58K | 1.00% |
| 2022-02-14 | Biotechnology Value Trading Fund OS LP | 107.58K | 1.00% |
| 2022-02-14 | BVF II GP LLC | 655.91K | 2.80% |
| 2022-02-14 | Biotechnology Value Fund II, L.P. | 655.91K | 2.80% |
| 2022-02-14 | Andrew N. Schiff | 2.87M | 12.33% |
| 2022-02-14 | MVA Investors, LLC | 56831.0 | 0.20% |
| 2022-02-14 | Aisling Capital Partners IV LLC | 2.87M | 12.33% |
| 2022-02-14 | Biotechnology Value Trading Fund OS LP | 107.58K | 1.00% |
| 2022-02-14 | BVF Partners OS Ltd. | 107.58K | 1.00% |
| 2022-02-14 | Biotechnology Value Fund, L.P. | 809.44K | 3.50% |
| 2022-02-14 | Aisling Capital IV, LP | 2.87M | 12.33% |
| 2022-02-14 | Aisling Capital IV, LP | 2.87M | 12.33% |
| 2022-02-14 | Andrew N. Schiff | 2.87M | 12.33% |
| 2022-02-14 | Aisling Capital Partners IV LLC | 2.87M | 12.33% |
| 2022-02-14 | Boxer Capital, LLC | 872.78K | 3.80% |
| 2022-02-14 | Joe Lewis | 872.78K | 3.80% |
| 2022-02-14 | MVA Investors, LLC | 56831.0 | 0.20% |
| 2022-02-14 | DRIEHAUS CAPITAL MANAGEMENT LLC | 1.98M | 8.54% |
| 2022-02-14 | Aaron I. Davis | 56831.0 | 0.20% |
| 2022-02-14 | BVF I GP LLC | 809.44K | 3.50% |
| 2022-02-08 | Mark McDade | 2.37M | 10.20% |
| 2022-02-08 | Qiming U.S. Healthcare Fund II, L.P. | 2.37M | 10.20% |
| 2022-02-08 | Mark McDade | 2.37M | 10.20% |
| 2022-02-08 | Qiming U.S. Healthcare GP II, LLC | 2.37M | 10.20% |
| 2022-02-08 | Qiming U.S. Healthcare Fund II, L.P. | 2.37M | 10.20% |
| 2022-02-08 | Gary Rieschel | 2.37M | 10.20% |
| 2022-02-08 | Gary Rieschel | 2.37M | 10.20% |
| 2022-02-08 | Qiming U.S. Healthcare GP II, LLC | 2.37M | 10.20% |
| 2022-01-18 | Vertex Venture Management Pte. Ltd. | 2.31M | 9.94% |
| 2022-01-18 | Vertex Global HC Fund II Pte. Ltd. | 2.31M | 9.94% |
| 2021-07-09 | Bihua Chen | 1.98M | 8.69% |
| 2021-07-09 | Cormorant Private Healthcare Fund III, LP | 1.55M | 6.79% |
| 2021-07-09 | Aaron I. Davis | 56831.0 | 0.20% |
| 2021-07-09 | Boxer Asset Management Inc. | 1.34M | 5.90% |
| 2021-07-09 | Corey Goodman | 2.61M | 11.43% |
| 2021-07-09 | Aaron Royston | 2.61M | 11.43% |
| 2021-07-09 | Joe Lewis | 1.34M | 5.90% |
| 2021-07-09 | venBio Global Strategic Fund III, L.P. | 2.61M | 11.43% |
| 2021-07-09 | venBio Global Strategic GP III, L.P. | 2.61M | 11.43% |
| 2021-07-09 | venBio Global Strategic Fund III, L.P. | 2.61M | 11.43% |
| 2021-07-09 | Robert Adelman | 2.61M | 11.43% |
| 2021-07-09 | Cormorant Global Healthcare GP, LLC | 403.18K | 1.77% |
| 2021-07-09 | venBio Global Strategic GP III, Ltd. | 2.61M | 11.43% |
| 2021-07-09 | Aaron Royston | 2.61M | 11.43% |
| 2021-07-09 | Aaron I. Davis | 56831.0 | 0.20% |
| 2021-07-09 | MVA Investors, LLC | 56831.0 | 0.20% |
| 2021-07-09 | Boxer Capital, LLC | 1.34M | 5.90% |
| 2021-07-09 | MVA Investors, LLC | 56831.0 | 0.20% |
| 2021-07-09 | Robert Adelman | 2.61M | 11.43% |
| 2021-07-09 | Boxer Asset Management Inc. | 1.34M | 5.90% |
| 2021-07-09 | Cormorant Global Healthcare Master Fund, LP | 403.18K | 1.77% |
| 2021-07-09 | Boxer Capital, LLC | 1.34M | 5.90% |
| 2021-07-09 | venBio Global Strategic GP III, L.P. | 2.61M | 11.43% |
| 2021-07-09 | Corey Goodman | 2.61M | 11.43% |
| 2021-07-09 | venBio Global Strategic GP III, Ltd. | 2.61M | 11.43% |
| 2021-07-09 | Joe Lewis | 1.34M | 5.90% |
| 2021-07-09 | Bihua Chen | 1.98M | 8.69% |
| 2021-07-09 | Cormorant Asset Management, LP | 1.98M | 8.69% |
| 2021-07-09 | Cormorant Private Healthcare GP III, LLC | 1.55M | 6.79% |
| 2021-07-09 | Cormorant Global Healthcare Master Fund, LP | 403.18K | 1.77% |
| 2021-07-09 | Cormorant Global Healthcare GP, LLC | 403.18K | 1.77% |
| 2021-07-09 | Cormorant Private Healthcare Fund III, LP | 1.55M | 6.79% |
| 2021-07-09 | Cormorant Private Healthcare GP III, LLC | 1.55M | 6.79% |
| 2021-07-09 | Cormorant Asset Management, LP | 1.98M | 8.69% |
ELEV Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2024-12-31 | $0.56 | 57.28M | $32.22M | $49.46M | $31.13M | $13.89M |
| 2023-12-31 | $0.54 | 34.08M | $18.3M | $49.26M | $30.14M | -$818.29K |
| 2022-12-31 | $0.95 | 23.27M | $22.1M | $45.92M | $29.44M | $5.62M |
| 2021-12-31 | $6.02 | 23.21M | $139.7M | $146.28M | -$ | -$6.58M |
| 2020-12-31 | $11.44 | 23.76M | $271.81M | $79.4M | -$ | $192.41M |
| 2019-12-31 | $11.44 | 23.76M | $271.81M | $1.74M | -$ | $270.07M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-03-31 | $0.26 | 59.17M | $15.33M | $60.49M | $31.25M | -$13.91M |
| 2024-12-31 | $0.56 | 59.12M | $33.26M | $49.46M | $31.13M | $14.93M |
| 2024-09-30 | $0.60 | 59.11M | $35.46M | $48.2M | $31.02M | $18.28M |
| 2024-06-30 | $2.86 | 59.02M | $168.79M | $59.45M | $30.92M | $140.26M |
| 2024-03-31 | $4.99 | 47.37M | $236.39M | $90.63M | $30.81M | $176.56M |
| 2023-12-31 | $0.54 | 42.42M | $22.78M | $49.26M | $30.14M | $3.66M |
| 2023-09-30 | $0.66 | 42.4M | $28.1M | $54.88M | $29.95M | $3.17M |
| 2023-06-30 | $1.52 | 27.58M | $41.91M | $106.32M | $29.77M | -$34.64M |
| 2023-03-31 | $1.90 | 23.62M | $44.88M | $55.9M | $29.6M | $18.57M |
| 2022-12-31 | $0.95 | 23.3M | $22.14M | $45.92M | $29.44M | $5.65M |
| 2022-09-30 | $1.13 | 23.29M | $26.32M | $52.59M | $29.27M | $3M |
| 2022-06-30 | $1.40 | 23.26M | $32.56M | $53.88M | -$ | -$21.32M |